SNPHF(SNPHF)
SNPHF
No analyst ratings available
No analyst price targets available for SNPHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $303.31B | $312.71B | $325.16B | $339.47B | $358.04B |
| Low | $291.54B | $292.44B | $308.25B | $321.81B | $339.42B |
| High | $310.78B | $334.51B | $340.61B | $355.60B | $375.06B |
| EBITDA Avg | $90.83B | $93.65B | $97.37B | $101.66B | $107.22B |
| Low | $87.31B | $87.57B | $92.31B | $96.37B | $101.64B |
| High | $93.07B | $100.17B | $102.00B | $106.49B | $112.32B |
| EBIT Avg | $76.68B | $79.05B | $82.20B | $85.82B | $90.51B |
| Low | $73.70B | $73.93B | $77.92B | $81.35B | $85.81B |
| High | $78.57B | $84.56B | $86.11B | $89.90B | $94.82B |
| Net Income Avg | $39.12B | $43.01B | $48.26B | $49.08B | $59.95B |
| Low | $36.47B | $40.10B | $45.00B | $45.76B | $55.89B |
| High | $41.54B | $45.67B | $51.24B | $52.11B | $63.65B |
| EPS Avg | $119.13 | $130.97 | $146.96 | $149.45 | $182.56 |
| Low | $111.07 | $122.12 | $137.02 | $139.34 | $170.21 |
| High | $126.49 | $139.07 | $156.04 | $158.68 | $193.84 |
| Analysts (Rev / EPS) | 9 / 1 | 9 / 1 | 4 / 1 | 4 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $72.87B | $77.79B | $84.90B | $77.27B |
| Low | $71.99B | $76.85B | $83.87B | $76.34B |
| High | $73.75B | $78.74B | $85.93B | $78.21B |
| EBITDA Avg | $21.82B | $23.30B | $25.43B | $23.14B |
| Low | $21.56B | $23.01B | $25.12B | $22.86B |
| High | $22.09B | $23.58B | $25.73B | $23.42B |
| EBIT Avg | $18.42B | $19.67B | $21.46B | $19.53B |
| Low | $18.20B | $19.43B | $21.20B | $19.30B |
| High | $18.65B | $19.90B | $21.72B | $19.77B |
| Net Income Avg | $9.76B | $11.24B | $12.20B | $8.57B |
| Low | $9.61B | $11.06B | $12.01B | $8.44B |
| High | $9.92B | $11.41B | $12.40B | $8.71B |
| EPS Avg | $29.98 | $34.50 | $37.47 | $26.32 |
| Low | $29.51 | $33.95 | $36.88 | $25.91 |
| High | $30.45 | $35.04 | $38.06 | $26.74 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 | 2 / 1 |